BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24130496)

  • 1. Quaternary structure of pathological prion protein as a determining factor of strain-specific prion replication dynamics.
    Laferrière F; Tixador P; Moudjou M; Chapuis J; Sibille P; Herzog L; Reine F; Jaumain E; Laude H; Rezaei H; Béringue V
    PLoS Pathog; 2013; 9(10):e1003702. PubMed ID: 24130496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physical relationship between infectivity and prion protein aggregates is strain-dependent.
    Tixador P; Herzog L; Reine F; Jaumain E; Chapuis J; Le Dur A; Laude H; Béringue V
    PLoS Pathog; 2010 Apr; 6(4):e1000859. PubMed ID: 20419156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossing Species Barriers Relies on Structurally Distinct Prion Assemblies and Their Complementation.
    Igel-Egalon A; Laferrière F; Tixador P; Moudjou M; Herzog L; Reine F; Torres JM; Laude H; Rezaei H; Béringue V
    Mol Neurobiol; 2020 Jun; 57(6):2572-2587. PubMed ID: 32239450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
    Crowell J; Hughson A; Caughey B; Bessen RA
    J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-dependent profile of misfolded prion protein aggregates.
    Morales R; Hu PP; Duran-Aniotz C; Moda F; Diaz-Espinoza R; Chen B; Bravo-Alegria J; Makarava N; Baskakov IV; Soto C
    Sci Rep; 2016 Feb; 6():20526. PubMed ID: 26877167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
    Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
    Prion; 2015; 9(5):394-403. PubMed ID: 26555211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
    Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
    J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
    Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
    J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
    Shoup D; Priola SA
    Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein misfolding cyclic amplification of prions.
    Saunders SE; Bartz JC; Shikiya RA
    J Vis Exp; 2012 Nov; (69):. PubMed ID: 23168797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
    Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
    Viruses; 2019 May; 11(5):. PubMed ID: 31083283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
    Wang F; Wang X; Abskharon R; Ma J
    Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a new form of human PrP(Sc) in vitro by interspecies transmission from cervid prions.
    Barria MA; Telling GC; Gambetti P; Mastrianni JA; Soto C
    J Biol Chem; 2011 Mar; 286(9):7490-5. PubMed ID: 21209079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions.
    Cescatti M; Saverioni D; Capellari S; Tagliavini F; Kitamoto T; Ironside J; Giese A; Parchi P
    J Virol; 2016 Jul; 90(14):6244-6254. PubMed ID: 27122583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion assemblies: structural heterogeneity, mechanisms of formation, and role in species barrier.
    Igel A; Fornara B; Rezaei H; Béringue V
    Cell Tissue Res; 2023 Apr; 392(1):149-166. PubMed ID: 36399162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free propagation of prion strains.
    Castilla J; Morales R; Saá P; Barria M; Gambetti P; Soto C
    EMBO J; 2008 Oct; 27(19):2557-66. PubMed ID: 18800058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.
    Shikiya RA; Eckland TE; Young AJ; Bartz JC
    Prion; 2014; 8(6):415-20. PubMed ID: 25482601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-resistant prions selectively decrease Shadoo protein.
    Watts JC; Stöhr J; Bhardwaj S; Wille H; Oehler A; Dearmond SJ; Giles K; Prusiner SB
    PLoS Pathog; 2011 Nov; 7(11):e1002382. PubMed ID: 22163178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.